CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Treatment options after sorafenib failure in patients with hepatocellular carcinoma
Imane El Dika, Ghassan K. Abou-Alfa
Clin Mol Hepatol. 2017;23(4):273-279.   Published online 2017 November 20    DOI: https://doi.org/10.3350/cmh.2017.0108

Excel Download

Treatment options after sorafenib failure in patients with hepatocellular carcinoma
Clinical and Molecular Hepatology. 2017;23(4):273-279   Crossref logo
Link1 Link2 Link3

Characteristics of 18 patients with hepatocellular carcinoma who obtained a complete response after treatment with sorafenib
Hepatology Research. 2014;44(13):1268-1276   Crossref logo
Link1

High toxicity of sorafenib for recurrent hepatocellular carcinoma after liver transplantation
Transplant International. 2012;25(11):1158-1164   Crossref logo
Link1

ALBI Grade Determines Post-Progression Survivals after Sorafenib Treatment Failure in Advanced Hepatocellular Carcinoma Patients: A Model for Second-Line Trial Selection
Journal of Hepatology. 2016;64(2):S699-S700   Crossref logo
Link1 Link2

Su1476 Sorafenib Associated Survival in Treatment Naïve Versus Treatment Experienced Patients With Advanced Hepatocellular Carcinoma
Gastroenterology. 2016;150(4):S516   Crossref logo
Link1 Link2

Treatment of Advanced Hepatocellular Carcinoma after Failure of Sorafenib Treatment: Subsequent or Additional Treatment Interventions Contribute to Prolonged Survival Postprogression
Gastroenterology Research and Practice. 2017;2017:1-10   Crossref logo
Link1 Link2 Link3

Hepatocellular Carcinoma Risk After Hepatitis C Cure
Current Treatment Options in Infectious Diseases. 2017;10(2):330-336   Crossref logo
Link1 Link2 Link3

Overall survival and good tolerability of long-term use of sorafenib after cytokine treatment: final results of a phase II trial of sorafenib in Japanese patients with metastatic renal cell carcinoma
BJU International. 2011;108(11):1813-1819   Crossref logo
Link1

Optimal therapy for patients with hepatocellular carcinoma and resistance or intolerance to sorafenib: challenges and solutions
Journal of Hepatocellular Carcinoma. 2017;Volume 4:131-138   Crossref logo
Link1 Link2

Sorafenib Treatment for Recurrent Hepatocellular Carcinoma After Liver Transplantation
Transplantation Proceedings. 2012;44(9):2754-2756   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.